4.Other Non-Current Assets
Other non-current assets consisted of the following (in thousands):
September 30, 2026
December 31, 2025
Clinical trial deposits
$
8,166
12,882
Deferred offering costs
227
709
Other
—
218
Total other assets
8,393
13,809
The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.
No definition available.